Review article · 2025 · Open access

Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy

Jiapeng Wang, Renjie Chen, Yongyi Xie, Xuanting Qin, You Zhou, Chuanshan Xu

Pharmaceutics, 17(7), 803 · Published 20 June 2025 · DOI 10.3390/pharmaceutics17070803

Open PDFView at the publisherCite this paper

In brief

“Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy” is a 2025 review article by Jiapeng Wang and 5 co-authors, published in Pharmaceutics. OpenAlex counts 56 citations as of 19 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.

Citations
56
Most cited in
2026 (48)
Field-weighted impact
3.82
References
138
Authors
6

Abstract

mRNA-based drug development is revolutionizing tumor therapies by enabling precise cancer immunotherapy, tumor suppressor gene restoration, and genome editing. However, the success of mRNA therapies hinges on efficient delivery systems that can protect mRNA from degradation and facilitate its release into the cytoplasm for translation. Despite the emergence of lipid nanoparticles (LNPs) as a clinically advanced platform for mRNA delivery, the efficiency of endo/lysosomal escape still represents a substantial bottleneck. Here, we summarize the intracellular fate of mRNA-loaded LNPs, focusing on their internalization pathways and processing within the endo-lysosomal system. We also discuss the impact of endo-lysosomal processes on mRNA delivery and explore potential strategies to improve mRNA escape from endo-lysosomal compartments. This review focuses on molecular engineering strategies to enhance LNP-mediated endo/lysosomal escape by optimizing lipid composition, including ionizable lipids, helper lipids, cholesterol, and PEGylated lipids. Additionally, ancillary enhancement strategies such as surface coating and shape management are discussed. By comprehensively integrating mechanistic insights into the journey of LNPs within the endo-lysosome system and recent advances in lipid chemistry, this review offers valuable inspiration for advancing mRNA-based cancer therapies by enabling robust protein expression.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, J., Chen, R., Xie, Y., Qin, X., Zhou, Y., & Xu, C. (2025). Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy. Pharmaceutics, 17(7), 803. https://doi.org/10.3390/pharmaceutics17070803

MLA 9

Wang, Jiapeng, et al. “Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy.” Pharmaceutics, vol. 17, no. 7, 2025, p. 803. https://doi.org/10.3390/pharmaceutics17070803.

Chicago

Wang, Jiapeng, Renjie Chen, Yongyi Xie, Xuanting Qin, You Zhou, and Chuanshan Xu. 2025. “Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy.” Pharmaceutics 17 (7): 803. https://doi.org/10.3390/pharmaceutics17070803.

Harvard

Wang, J. et al. (2025) ‘Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy’, Pharmaceutics, 17(7), p. 803. doi:10.3390/pharmaceutics17070803.

IEEE

J. Wang, R. Chen, Y. Xie, X. Qin, Y. Zhou, and C. Xu, “Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy,” Pharmaceutics, vol. 17, no. 7, p. 803, 2025, doi: 10.3390/pharmaceutics17070803.

BibTeX

@article{wang2025endo,
  title     = {{Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy}},
  author    = {Wang, Jiapeng and Chen, Renjie and Xie, Yongyi and Qin, Xuanting and Zhou, You and Xu, Chuanshan},
  journal   = {Pharmaceutics},
  year      = {2025},
  volume    = {17},
  number    = {7},
  pages     = {803},
  doi       = {10.3390/pharmaceutics17070803},
  url       = {https://doi.org/10.3390/pharmaceutics17070803}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • mRNA delivery
  • endosomal escape
  • lysosomal escape
  • cancer immunotherapy
  • ionizable lipids
  • helper lipids
  • cholesterol

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Wang, J., Chen, R., Xie, Y., Qin, X., Zhou, Y., & Xu, C. (2025). Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy. Pharmaceutics, 17(7), 803. https://doi.org/10.3390/pharmaceutics17070803

How many times has this paper been cited?

56 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmaceutics: sign in and open the PDF from this page.

Who wrote this paper?

Jiapeng Wang, Renjie Chen, Yongyi Xie, Xuanting Qin, You Zhou, Chuanshan Xu.

What is the DOI of this paper?

10.3390/pharmaceutics17070803, permanently at https://doi.org/10.3390/pharmaceutics17070803. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.